SCS
IMMU

Syquant Capital SAS’s Immunomedics Inc IMMU Stock Holding History

Syquant Capital SAS’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-267,925
Closed -$22.8M – 111
2020
Q3 		$22.8M Buy
+267,925
New +$13.5M 11.6% 2

Syquant Capital SAS's IMMU Position: Q4 2020 in Review

Syquant Capital SAS sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 267,925 shares — an estimated $22.8M sold.

Syquant Capital SAS first reported a position in IMMU in Q3 2020 and held it in 1 quarter. The position peaked at $22.8M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Syquant Capital SAS reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Syquant Capital SAS sold 267,925 Immunomedics Inc shares in Q4 2020, an estimated $22.8M.
  • Syquant Capital SAS first reported a position in Immunomedics Inc in Q3 2020 and held it in 1 quarter.
  • Syquant Capital SAS's Immunomedics Inc position peaked at $22.8M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Syquant Capital SAS's 13F filing for Q4 2020, filed 5 Feb 2021.